NRG1 and depressive disorder: These properties were demonstrated in a post-stroke depression model, where an increase in dopamine and serotonin levels was observed in the brains of treated rats, along with an upregulation of the NRG-1-mediated MEK/ERK signaling pathway, contributing to more effective treatment of depression.